Summary & Overview
HCPCS G8935: Clinician-Prescribed ACE Inhibitor or ARB Therapy
HCPCS Level II code G8935 documents a clinician-prescribed angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy. The code captures the clinical action of initiating or prescribing guideline-relevant renin–angiotensin system blockade, a common intervention for hypertension, heart failure, and certain renal-protective indications. Nationally, standardized documentation of such prescriptions supports quality measurement, care coordination, and payer coverage decisions.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent, typical settings where it is used, and the types of claims contexts in which it appears. The publication summarizes available benchmarks and common billing practices tied to G8935, highlights relevant policy considerations for payers and providers, and provides clinical context about ACE inhibitor and ARB prescribing as it relates to quality measurement.
Intended takeaways include: what G8935 represents and why it is recorded, which payers commonly recognize the code, and where to look for policy updates or payer-specific coverage guidance. Data not available in the input will be explicitly noted in relevant sections of the full publication.
Billing Code Overview
HCPCS Level II code G8935 indicates clinician prescribed angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy. This entry documents the prescription action by a clinician for ACE inhibitor or ARB medication intended to manage conditions such as hypertension or certain forms of heart failure.
Service Type: Medication management / prescription
Typical Site of Service: Outpatient clinic, physician office, or other ambulatory care settings where prescriptions are issued
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old male with a history of hypertension and newly identified reduced left ventricular ejection fraction on echocardiogram presenting to a primary care clinic or cardiology outpatient visit for medical management. The clinician documents an indication for initiation or continuation of renin-angiotensin system blockade and prescribes an angiotensin converting enzyme inhibitor (ACE inhibitor) or an angiotensin receptor blocker (ARB) for blood pressure control and cardioprotective benefit.
The clinical workflow includes medication reconciliation, review of prior adverse reactions or angioedema history, assessment of serum potassium and renal function prior to initiation or dose escalation, counseling regarding potential side effects (cough with ACE inhibitors, hyperkalemia, renal function changes), prescription entry into the EHR, and documentation of the prescription decision and clinical rationale in the visit note. Typical sites of service are outpatient clinics (primary care or cardiology), community health centers, and telemedicine visits where prescribing occurs. Monitoring follow-up is arranged with laboratory testing and a return visit or remote check-in to assess tolerance and response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation supports substantially greater physician work than typical for the visit associated with complex medication management or counseling for ACE inhibitor/ARB initiation. |
23 | Unusual anesthesia | Not typically applicable; only used if unusual anesthesia is required during a visit related to this service. |
52 | Reduced services | Use when the prescribing service was partially reduced or abbreviated compared with usual practice. |
53 | Discontinued procedure | Use if the prescribing process was started but halted before completion for clinical reasons. |
54 | Surgical care only | Rarely applicable; use if only the procedural/surgical portion was performed separate from medical management. |
55 | Postoperative management only | Rarely applicable; use if only post-op medication adjustments are provided. |
56 | Preoperative management only | Use when ACE inhibitor/ARB prescription or adjustment was done solely as preoperative medication management. |
62 | Two surgeons | Not typically applicable for pharmacologic prescribing; only if two physicians of different specialties share responsibility for the medication decision. |
AS | Non‑participating anesthesiologist | Not applicable to routine prescribing; included for completeness from provided list. |
CO | Worker’s compensation patient | Use when the patient’s care is billed to a worker’s compensation carrier and payer requires modifier. |
CQ | Service furnished under a research protocol, clinical research study | Use when prescription is part of a qualifying clinical research trial per payer rules. |
FX | Left jaw | Not applicable to prescribing; anatomic modifier retained from input but generally unused here. |
FY | Right jaw | Not applicable to prescribing; anatomic modifier retained from input but generally unused here. |
QK | Medical direction of 2–4 auxiliary personnel | Use when the clinician medically directs auxiliary staff who perform parts of care related to medication initiation under applicable billing rules. |
QX | Certified nurse midwife or physician assistant service | Use when a qualified non-physician practitioner provides the prescribing service under their own billing identifiers. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Cardiology | Cardiologists commonly initiate ACE inhibitor/ARB therapy for heart failure, post-MI remodeling prevention, and hypertension management. |
| 207R00000X | Internal Medicine | Internists/primary care clinicians frequently prescribe ACE inhibitors/ARBs for hypertension and chronic kidney disease management. |
| 207P00000X | Family Medicine | Family physicians manage chronic hypertension and initiate ACE inhibitor/ARB therapy in outpatient settings. |
| 163WK0200X | Nurse Practitioner | Nurse practitioners in primary care or cardiology clinics commonly prescribe ACE inhibitors/ARBs under state scope of practice. |
| 363LP0200X | Physician Assistant | Physician assistants frequently provide medication management and prescribing in outpatient and hospital clinics. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I10 | Essential (primary) hypertension | Primary indication for initiating ACE inhibitor or ARB therapy for blood pressure control. |
I50.22 | Chronic systolic (congestive) heart failure | ACE inhibitors/ARBs are guideline-directed therapy to reduce morbidity and mortality in systolic heart failure. |
I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | ACE inhibitor/ARB therapy may be used post‑myocardial infarction or for cardioprotection in coronary disease. |
E11.22 | Type 2 diabetes mellitus with diabetic chronic kidney disease | ACE inhibitors/ARBs provide renal protection and are commonly prescribed for diabetic kidney disease. |
N18.9 | Chronic kidney disease, unspecified | ACE inhibitor/ARB use requires renal function assessment; indicated in certain CKD stages for proteinuric disease. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
99213 | Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes | Common visit level for routine medication initiation, counseling, and follow-up when prescribing ACE inhibitor/ARB. |
99214 | Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes | Used when the medication decision requires moderate complexity, extensive counseling, or management of comorbidities. |
36415 | Collection of venous blood by venipuncture | Often performed before or after initiation to obtain baseline serum creatinine and potassium for safety monitoring. |
93000 | Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | May be performed in cardiac patients prior to medication changes in the ambulatory setting. |
93306 | Echocardiography, transthoracic, real-time with image documentation, complete, with spectral and color Doppler | Performed in patients with heart failure or reduced ejection fraction to guide initiation of ACE inhibitor/ARB therapy and monitor response. |